Validation of ANG-1 and P-SEL as biomarkers of post-COVID-19 conditions using data from the Biobanque qu ébécoise de la COVID-19 (BQC-19)

AbstractThe quest for understanding and managing the long-term effects of COVID-19, often referred to as Long COVID or post-COVID-19 condition (PCC), remains an active research area. Recent findings highlighted angiopoietin-1 (ANG-1) and p-selectin (P-SEL) as potential diagnostic markers, but validation is essential, given the inconsistency in COVID-19 biomarker studies. Leveraging the biobanque qu ébécoise de la COVID-19 (BQC19) biobank, we analyzed the data of 249 participants. Both ANG-1 and P-SEL levels were significantly higher in patients with PCC participants compared with control subjects at 3 months using the Mann-Whitney U test. We managed to reproduce and validate the findings, em phasizing the importance of collaborative biobanking efforts in enhancing the reproducibility and credibility of Long COVID research outcomes.
Source: Clinical Proteomics - Category: Biochemistry Source Type: research
More News: Biochemistry | COVID-19 | Study